MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway
Crossref DOI link: https://doi.org/10.1186/s12935-019-0818-x
Published Online: 2019-04-24
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Xin
Tang, Fen
Weng, Zeping
Zhou, Mengyao
Zhang, Qing
Text and Data Mining valid from 2019-04-24
Article History
Received: 19 October 2018
Accepted: 8 April 2019
First Online: 24 April 2019